Mizote Y - Search Results

1

Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells.

Harada Y, Mizote Y, Suzuki T, Hirayama A, Ikeda S, Nishida M, Hiratsuka T, Ueda A, Imagawa Y, Maeda K, Ohkawa Y, Murai J, Freeze HH, Miyoshi E, Higashiyama S, Udono H, Dohmae N, Tahara H, Taniguchi N. Harada Y, et al. Among authors: mizote y. Elife. 2023 Jul 18;12:e83870. doi: 10.7554/eLife.83870. Elife. 2023. PMID: 37461317 Free PMC article.

2

TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD).

Mizote Y, Wakamatsu K, Ito S, Uenaka A, Ohue Y, Kurose K, Isobe M, Ito A, Tamura Y, Honda H, Yamashita T, Nohara S, Oka M, Jimbow K, Nakayama E. Mizote Y, et al. J Dermatol Sci. 2014 Mar;73(3):209-15. doi: 10.1016/j.jdermsci.2013.11.006. Epub 2013 Nov 14. J Dermatol Sci. 2014. PMID: 24315204

3

Negative influence of programmed death-1-ligands on the survival of esophageal cancer patients treated with chemotherapy.

Tanaka K, Miyata H, Sugimura K, Kanemura T, Hamada-Uematsu M, Mizote Y, Yamasaki M, Wada H, Nakajima K, Takiguchi S, Mori M, Doki Y, Tahara H. Tanaka K, et al. Among authors: mizote y. Cancer Sci. 2016 Jun;107(6):726-33. doi: 10.1111/cas.12938. Epub 2016 May 16. Cancer Sci. 2016. PMID: 27015293 Free PMC article.

4

Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.

Kanemura T, Miyata H, Makino T, Tanaka K, Sugimura K, Hamada-Uematsu M, Mizote Y, Uchida H, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Wada H, Nakajima K, Takiguchi S, Mori M, Doki Y, Tahara H. Kanemura T, et al. Among authors: mizote y. Cancer Sci. 2018 Nov;109(11):3393-3402. doi: 10.1111/cas.13785. Epub 2018 Sep 22. Cancer Sci. 2018. PMID: 30156356 Free PMC article.

5

Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.

Kawachi H, Kunimasa K, Kukita Y, Nakamura H, Honma K, Kawamura T, Inoue T, Tamiya M, Kuhara H, Nishino K, Mizote Y, Akazawa T, Tahara H, Kumagai T. Kawachi H, et al. Among authors: mizote y. Immunotherapy. 2021 Jul;13(10):799-806. doi: 10.2217/imt-2020-0311. Epub 2021 May 25. Immunotherapy. 2021. PMID: 34030451 Free article.

6

Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic cancer.

Ikezawa K, Ekawa T, Hasegawa S, Kai Y, Takada R, Yamai T, Fukutake N, Ogawa H, Akazawa T, Mizote Y, Tatsumi K, Nagata S, Asukai K, Takahashi H, Ohkawa K, Tahara H. Ikezawa K, et al. Among authors: mizote y. Endosc Int Open. 2022 Jan 11;10(1):E82-E87. doi: 10.1055/a-1713-3404. eCollection 2022 Jan. Endosc Int Open. 2022. PMID: 35036290 Free PMC article.

7

A Method for Extending Target Regions of Genomic Profiling by Combining a Custom Probe Pool with a Commercial Targeted Panel.

Kukita Y, Kunimasa K, Akazawa T, Mizote Y, Tahara H. Kukita Y, et al. Among authors: mizote y. J Appl Lab Med. 2023 Nov 2;8(6):1065-1073. doi: 10.1093/jalm/jfad069. J Appl Lab Med. 2023. PMID: 37748758

8

Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

Wada H, Isobe M, Kakimi K, Mizote Y, Eikawa S, Sato E, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, Yamasaki M, Miyata H, Matsushita H, Udono H, Seto Y, Yamada K, Nishikawa H, Pan L, Venhaus R, Oka M, Doki Y, Nakayama E. Wada H, et al. Among authors: mizote y. J Immunother. 2014 Feb-Mar;37(2):84-92. doi: 10.1097/CJI.0000000000000017. J Immunother. 2014. PMID: 24509171 Clinical Trial.

9

Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.

Mizote Y, Taniguchi T, Tanaka K, Isobe M, Wada H, Saika T, Kita S, Koide Y, Uenaka A, Nakayama E. Mizote Y, et al. Vaccine. 2010 Jul 19;28(32):5338-46. doi: 10.1016/j.vaccine.2010.05.044. Vaccine. 2010. PMID: 20665979 Free article.

10

Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients.

Mizote Y, Uenaka A, Isobe M, Wada H, Kakimi K, Saika T, Kita S, Koide Y, Oka M, Nakayama E. Mizote Y, et al. Vaccine. 2014 Feb 12;32(8):957-64. doi: 10.1016/j.vaccine.2013.12.042. Epub 2014 Jan 5. Vaccine. 2014. PMID: 24397899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page